[ad_1]
GoodRx Holdings, Inc. (NASDAQ:GDRX) is without doubt one of the 12 Finest American Penny Shares to Purchase Proper Now. On November 6, Goldman Sachs elevated its value goal on GoodRx Holdings, Inc. (NASDAQ:GDRX) from $3.75 to $4 and saved a Impartial score.
This resolution got here after the corporate reported its outcomes for the third quarter of 2025. The analysis agency highlighted that GoodRx Holdings, Inc. (NASDAQ:GDRX) is engaged on increasing accessibility and affordability applications. The corporate can be engaged in talks about collaborating within the TrumpRx initiative.
Goldman Sachs famous that there are ongoing challenges within the trade. These embrace uncertainties concerning the Reasonably priced Care Act market subsidies and Medicaid assist. The agency identified that GoodRx Holdings, Inc. (NASDAQ:GDRX) delivered a robust efficiency by means of its pharma producer options within the third quarter of 2025.
Moreover, Goldman Sachs talked about the corporate’s new model marketing campaign, which helps increase consciousness of its shopper services and products. These embrace new subscription providers that target hair loss and weight reduction remedies.
Nevertheless, the analysis agency cautioned that GoodRx Holdings, Inc. (NASDAQ:GDRX) may expertise volatility. This danger comes from potential regulatory modifications and platform launches from Washington. Client affordability challenges are additionally anticipated to stay an essential space for traders.
GoodRx Holdings, Inc. (NASDAQ:GDRX) is an American firm that’s recognized for its digital healthcare platform that connects shoppers, healthcare professionals, payers, PBMs, pharma producers, and retail pharmacies to make medicines extra reasonably priced and accessible.
Whereas we acknowledge the potential of GDRX as an funding, we imagine sure AI shares provide better upside potential and carry much less draw back danger. If you happen to’re in search of a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring development, see our free report on the finest short-term AI inventory.
READ NEXT: 10 Shares Underneath $20 to Purchase In accordance with Analysts and 12 Finest Performing Shares within the Final 3 Months.
Disclosure: None. This text is initially revealed at Insider Monkey.
[ad_2]
